263 related articles for article (PubMed ID: 28419376)
41. Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM).
Ping PA; Zakaria R; Islam MA; Yaacob LH; Muhamad R; Wan Mohamad WMZ; Yusoff HM
Int J Environ Res Public Health; 2021 Jan; 18(1):. PubMed ID: 33406582
[TBL] [Abstract][Full Text] [Related]
42. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
43. [Screening contacts for latent tuberculosis infection (LTBI) using an interferon test in Paris in 2009].
Fournier A; Antoun F; Collignon A; Muller G; Rouvier J; Ayache B; Guesnon MS; Larnaudie S
Rev Mal Respir; 2012 Jan; 29(1):28-39. PubMed ID: 22240217
[TBL] [Abstract][Full Text] [Related]
44. Diabetes Mellitus Among Pulmonary Tuberculosis Patients From 4 Tuberculosis-endemic Countries: The TANDEM Study.
Ugarte-Gil C; Alisjahbana B; Ronacher K; Riza AL; Koesoemadinata RC; Malherbe ST; Cioboata R; Llontop JC; Kleynhans L; Lopez S; Santoso P; Marius C; Villaizan K; Ruslami R; Walzl G; Panduru NM; Dockrell HM; Hill PC; Mc Allister S; Pearson F; Moore DAJ; Critchley JA; van Crevel R
Clin Infect Dis; 2020 Feb; 70(5):780-788. PubMed ID: 30958536
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of proximate risk factors of active tuberculosis in latent tuberculosis infection: A cross-sectional study from South India.
Munisankar S; Rajamanickam A; Balasubramanian S; Muthusamy S; Menon PA; Ahamed SF; Whalen C; Gumne P; Kaur I; Nadimpalli V; Deverakonda A; Chen Z; Otto JD; Habitegiyorgis T; Kandaswamy H; Babu S
Front Public Health; 2022; 10():1011388. PubMed ID: 36276400
[TBL] [Abstract][Full Text] [Related]
46. Screening of patients with diabetes mellitus for tuberculosis in community health settings in China.
Lin Y; Innes A; Xu L; Li L; Chen J; Hou J; Mi F; Kang W; Harries AD
Trop Med Int Health; 2015 Aug; 20(8):1073-80. PubMed ID: 25877338
[TBL] [Abstract][Full Text] [Related]
47. Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.
Aguilera XP; González C; Nájera-De Ferrari M; Hirmas M; Delgado I; Olea A; Lezaeta L; Montaña A; González P; Hormazábal JC; Fernández J; García C; Herrera T
Int J Tuberc Lung Dis; 2016 Jan; 20(1):63-70. PubMed ID: 26688530
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
[TBL] [Abstract][Full Text] [Related]
49. Latent tuberculosis infection and associated risk indicators in pastoral communities in southern Ethiopia: a community based cross-sectional study.
Teklu T; Legesse M; Medhin G; Zewude A; Chanyalew M; Zewdie M; Wondale B; Haile-Mariam M; Pieper R; Ameni G
BMC Public Health; 2018 Feb; 18(1):266. PubMed ID: 29454325
[TBL] [Abstract][Full Text] [Related]
50. Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study.
Wysocki AD; Villa TC; Arakawa T; Brunello ME; Vendramini SH; Monroe AA; Kritski AL
PLoS One; 2016; 11(6):e0155348. PubMed ID: 27285720
[TBL] [Abstract][Full Text] [Related]
51. Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection.
Reichler MR; Khan A; Yuan Y; Chen B; McAuley J; Mangura B; Sterling TR;
Clin Infect Dis; 2020 Oct; 71(7):1627-1634. PubMed ID: 32044987
[TBL] [Abstract][Full Text] [Related]
52. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.
Sagili KD; Muniyandi M; Shringarpure K; Singh K; Kirubakaran R; Rao R; Tonsing J; Sachdeva KS; Tharyan P
Trop Med Int Health; 2022 Oct; 27(10):842-863. PubMed ID: 35927930
[TBL] [Abstract][Full Text] [Related]
53. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
Saunders MJ; Koh GC; Small AD; Dedicoat M
Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
[TBL] [Abstract][Full Text] [Related]
54. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
56. Overweight, Obesity, and Older Age Favor Latent Tuberculosis Infection among Household Contacts in Low Tuberculosis-Incidence Settings within Panama.
Cubilla-Batista I; Ruiz N; Sambrano D; Castillo J; de Quinzada MO; Gasteluiturri B; Goodridge A
Am J Trop Med Hyg; 2019 May; 100(5):1141-1144. PubMed ID: 30915957
[TBL] [Abstract][Full Text] [Related]
57. Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia.
Khoufi EAA
Pan Afr Med J; 2021; 38():362. PubMed ID: 34367441
[TBL] [Abstract][Full Text] [Related]
58. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.
Shu CC; Hsu CL; Lee CY; Wang JY; Wu VC; Yang FJ; Wang JT; Yu CJ; Lee LN
PLoS One; 2015; 10(4):e0124104. PubMed ID: 25919813
[TBL] [Abstract][Full Text] [Related]
60. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
Davidow AL
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
